Regulus Therapeutics
RGLS
#7340
Rank
NZ$1.00 B
Marketcap
NZ$14.54
Share price
0.00%
Change (1 day)
447.47%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$1.00 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of NZ$1.00 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.97 B445.4%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$171.08 B 16,894.99%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$59.42 B 5,803.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$215.19 B 21,276.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$439.95 B 43,603.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$166.00 B 16,390.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$54.62 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.30 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$55.47 B 5,411.05%๐Ÿ‡บ๐Ÿ‡ธ USA